Bone Marrow Features in Patients With Acute Myeloid Leukemia Treated With Novel Targeted Isocitrate Dehydrogenase 1/2 Inhibitors

This case report aimed to review the bone marrow features of patients with acute myeloid leukemia (AML) treated with isocitrate dehydrogenase 1/2 (IDH1/2) inhibitors. Five patients with AML treated with an IDH1/2 inhibitor were identified and retrospectively reviewed. We described the morphologic an...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagiya, Ashley, Vaidya, Poorva, Khedro, Tarek, Yaghmour, Bassam, Siddiqi, Imran, Yaghmour, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940036/
https://www.ncbi.nlm.nih.gov/pubmed/31921378
http://dx.doi.org/10.14740/wjon1231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940036/
https://www.ncbi.nlm.nih.gov/pubmed/31921378
http://dx.doi.org/10.14740/wjon1231

Ejemplares similares